294 related articles for article (PubMed ID: 29688260)
1. Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells.
Prusinski Fernung LE; Yang Q; Sakamuro D; Kumari A; Mas A; Al-Hendy A
Biol Reprod; 2018 Oct; 99(4):735-748. PubMed ID: 29688260
[TBL] [Abstract][Full Text] [Related]
2. TGFβ signaling links early life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells.
Bariani MV; Cui YH; Ali M; Bai T; Grimm SL; Coarfa C; Walker CL; He YY; Yang Q; Al-Hendy A
Cell Mol Life Sci; 2023 Sep; 80(10):288. PubMed ID: 37689587
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 Ameliorates DNA Damage Caused by Developmental Exposure to Endocrine Disruptors in the Uterine Myometrial Stem Cells of Eker Rats.
Elkafas H; Ali M; Elmorsy E; Kamel R; Thompson WE; Badary O; Al-Hendy A; Yang Q
Cells; 2020 Jun; 9(6):. PubMed ID: 32545544
[TBL] [Abstract][Full Text] [Related]
4. A Preliminary Study: Human Fibroid Stro-1
Prusinski Fernung LE; Al-Hendy A; Yang Q
Reprod Sci; 2019 May; 26(5):619-638. PubMed ID: 29954254
[TBL] [Abstract][Full Text] [Related]
5. Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis.
Mas A; Stone L; O'Connor PM; Yang Q; Kleven D; Simon C; Walker CL; Al-Hendy A
Stem Cells; 2017 Mar; 35(3):666-678. PubMed ID: 27739139
[TBL] [Abstract][Full Text] [Related]
6. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats.
Cook JD; Davis BJ; Goewey JA; Berry TD; Walker CL
Reprod Sci; 2007 Feb; 14(2):121-36. PubMed ID: 17636224
[TBL] [Abstract][Full Text] [Related]
7. Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic Regulation.
Yang Q; Diamond MP; Al-Hendy A
Front Pharmacol; 2016; 7():40. PubMed ID: 26973527
[TBL] [Abstract][Full Text] [Related]
8. Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells.
Elkafas H; Qiwei Y; Al-Hendy A
Semin Reprod Med; 2017 Nov; 35(6):481-486. PubMed ID: 29100235
[No Abstract] [Full Text] [Related]
9. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
[TBL] [Abstract][Full Text] [Related]
10. Endocrine-disrupting chemicals and uterine fibroids.
Katz TA; Yang Q; Treviño LS; Walker CL; Al-Hendy A
Fertil Steril; 2016 Sep; 106(4):967-77. PubMed ID: 27553264
[TBL] [Abstract][Full Text] [Related]
11. Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.
Yang Q; Laknaur A; Elam L; Ismail N; Gavrilova-Jordan L; Lue J; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Oct; 23(10):1314-25. PubMed ID: 27036951
[TBL] [Abstract][Full Text] [Related]
12. Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas.
Park MJ; Shen H; Kim NH; Gao F; Failor C; Knudtson JF; McLaughlin J; Halder SK; Heikkinen TA; Vahteristo P; Al-Hendy A; Schenken RS; Boyer TG
J Clin Endocrinol Metab; 2018 Nov; 103(11):4283-4292. PubMed ID: 30099503
[TBL] [Abstract][Full Text] [Related]
13. TGFβ signaling links early-life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells.
Bariani MV; Cui YH; Ali M; Bai T; Grimm SL; Coarfa C; Walker CL; He YY; Yang Q; Al-Hendy A
Res Sq; 2023 Jun; ():. PubMed ID: 37333266
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the mediator kinase-dependent myometrial stem cell phosphoproteome.
Barron L; Khadka S; Schenken R; He L; Blenis J; Blagg J; Chen SF; Tsai KL; Boyer TG
F S Sci; 2021 Nov; 2(4):383-395. PubMed ID: 35559861
[TBL] [Abstract][Full Text] [Related]
16. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
[TBL] [Abstract][Full Text] [Related]
17. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance.
Cook JD; Davis BJ; Cai SL; Barrett JC; Conti CJ; Walker CL
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8644-9. PubMed ID: 15937110
[TBL] [Abstract][Full Text] [Related]
18. Developmental reprogramming of myometrial stem cells by endocrine disruptor linking to risk of uterine fibroids.
Yang Q; Ali M; Treviño LS; Mas A; Al-Hendy A
Cell Mol Life Sci; 2023 Aug; 80(9):274. PubMed ID: 37650943
[TBL] [Abstract][Full Text] [Related]
19. Introduction of Somatic Mutation in MED12 Induces Wnt4/β-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell.
El Andaloussi A; Al-Hendy A; Ismail N; Boyer TG; Halder SK
Reprod Sci; 2020 Mar; 27(3):823-832. PubMed ID: 32046450
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.
Park MJ; Shen H; Spaeth JM; Tolvanen JH; Failor C; Knudtson JF; McLaughlin J; Halder SK; Yang Q; Bulun SE; Al-Hendy A; Schenken RS; Aaltonen LA; Boyer TG
J Biol Chem; 2018 Mar; 293(13):4870-4882. PubMed ID: 29440396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
